These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6340614)

  • 1. Chemotherapy-induced transverse white lines in the fingernails.
    James WD; Odom RB
    Arch Dermatol; 1983 Apr; 119(4):334-5. PubMed ID: 6340614
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphoma.
    Connors JM
    Important Adv Oncol; 1990; ():227-33. PubMed ID: 2182521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
    Miles SA; McGratten M
    J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutropenic fever following chemotherapy in a patient with lymphoma.
    Book L
    Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
    Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.
    Armitage JO; Corder MP; Leimert JT; Dick FR; Elliot TE
    Cancer Treat Rep; 1980; 64(4-5):649-54. PubMed ID: 7000347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lingua villosa nigra after chemotherapy].
    Lkhoyaali S; Errihani H
    Pan Afr Med J; 2014; 18():69. PubMed ID: 25400836
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
    Elias L; Portlock CS; Rosenberg SA
    Cancer; 1978 Oct; 42(4):1705-10. PubMed ID: 361209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
    Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: initial safety and toxicity data.
    Salvatore JR; Harrington J; Kummet T
    Bioelectromagnetics; 2003 Oct; 24(7):524-7. PubMed ID: 12955758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A male with primary breast lymphoma.
    Miura Y; Nishizawa M; Kaneko H; Watanabe M; Tsudo M
    Am J Hematol; 2009 Mar; 84(3):191-2. PubMed ID: 18932237
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E
    Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
    [No Abstract]   [Full Text] [Related]  

  • 16. Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.
    Tsavaris N; Kosmas C; Vadiaka M; Giannouli S; Siakantaris MP; Vassilakopoulos T; Pangalis GA
    Anticancer Res; 2002; 22(3):1845-8. PubMed ID: 12168880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study.
    Rueda A; Sabin P; Rifá J; Llanos M; Gómez-Codina J; Lobo F; García R; Herrero J; Provencio M; Jara C;
    Hematol Oncol; 2008 Mar; 26(1):27-32. PubMed ID: 17868190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interstitial pneumonia in patients treated with VACOP-B therapy for malignant lymphoma].
    Sakai C; Goto S; Nakaseko C; Kumagai K; Takagi T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):423-6. PubMed ID: 9492839
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
    Kornacker M; Kraemer A; Leo E; Ho AD
    Ann Hematol; 2002 Feb; 81(2):103-5. PubMed ID: 11907791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.